Literature DB >> 26029993

Overexpression of the FoxO1 Ameliorates Mesangial Cell Dysfunction in Male Diabetic Rats.

Guijun Qin1, Yingni Zhou1, Feng Guo1, Lei Ren1, Lina Wu1, Yuanyuan Zhang1, Xiaojun Ma1, Qingzhu Wang1.   

Abstract

The dysfunction of mesangial cells (MCs) in high-glucose (HG) conditions plays pivotal role in inducing glomerular sclerosis by causing the imbalance between generation and degradation of extracellular matrix (ECM) proteins, which ultimately leads to diabetic nephropathy. This study was designed to determine the function of forkhead box protein O1 (FoxO1), an important transcription factors in regulating cell metabolism and oxidative stress, in MCs in HG conditions. Up-regulation of fibronectin, collagen type IV, and plasminogen activator inhibitor (PAI-1) was observed under HG conditions in vivo and in vitro, accompanied with elevation of protein kinase B (Akt) phosphorylation and reduction of FoxO1 bioactivity. After overexpression of constitutively active (CA) FoxO1 in vivo and in vitro by using lentivirus vector, in vivo and in vitro, FoxO1 expression and activity was increased, in accordance with up-regulation of antioxidative genes (catalase and superoxide dismutase, leading to alleviated oxidative stress as well as attenuated Akt activity, whereas overexpression of wild type-FoxO1 only expressed partial effect. Moreover, CA-FoxO1 decreased the expression of fibronectin, collagen type IV, and PAI-1, causing amelioration of renal pathological changes and decrease of ECM protein deposition in glomerulus. Overexpression of CA-FoxO1 in renal cortex also decreased activin type-I receptor-like kinase-5 levels and increased signaling mothers against decapentaplegic (Smad) 7 levels, and simultaneously inhibited Smad3 phosphorylation. Results from in vitro study indicated that increased combination of FoxO1 and Smad3 may interfere with the function of Smad3, including Smad3 phosphorylation and translocation, interaction with cAMP response element binding protein (CREB)-binding protein, and binding with PAI-1 promoter. Together, our findings shed light on the novel function of FoxO1 in inhibiting ECM deposition, which is beneficial to ameliorate MC dysfunction.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26029993      PMCID: PMC5414709          DOI: 10.1210/me.2014-1372

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  54 in total

Review 1.  Mechanisms of TGF-beta signaling from cell membrane to the nucleus.

Authors:  Yigong Shi; Joan Massagué
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

Review 2.  Gene delivery by lentivirus vectors an overview.

Authors:  Tal Kafri
Journal:  Methods Mol Biol       Date:  2004

3.  Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene.

Authors:  S Dennler; S Itoh; D Vivien; P ten Dijke; S Huet; J M Gauthier
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

4.  Mesangial cell NADPH oxidase upregulation in high glucose is protein kinase C dependent and required for collagen IV expression.

Authors:  L Xia; H Wang; H J Goldberg; S Munk; I G Fantus; C I Whiteside
Journal:  Am J Physiol Renal Physiol       Date:  2005-08-30

5.  Downregulation of catalase by reactive oxygen species via PI 3 kinase/Akt signaling in mesangial cells.

Authors:  Balachandar Venkatesan; Lenin Mahimainathan; Falguni Das; Nandini Ghosh-Choudhury; Goutam Ghosh Choudhury
Journal:  J Cell Physiol       Date:  2007-05       Impact factor: 6.384

6.  TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia.

Authors:  Kazuhito Naka; Takayuki Hoshii; Teruyuki Muraguchi; Yuko Tadokoro; Takako Ooshio; Yukio Kondo; Shinji Nakao; Noboru Motoyama; Atsushi Hirao
Journal:  Nature       Date:  2010-02-04       Impact factor: 49.962

7.  Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase.

Authors:  Anne Brunet; Lora B Sweeney; J Fitzhugh Sturgill; Katrin F Chua; Paul L Greer; Yingxi Lin; Hien Tran; Sarah E Ross; Raul Mostoslavsky; Haim Y Cohen; Linda S Hu; Hwei-Ling Cheng; Mark P Jedrychowski; Steven P Gygi; David A Sinclair; Frederick W Alt; Michael E Greenberg
Journal:  Science       Date:  2004-02-19       Impact factor: 47.728

8.  Fractalkine and its receptor mediate extracellular matrix accumulation in diabetic nephropathy in mice.

Authors:  K H Song; J Park; J H Park; R Natarajan; H Ha
Journal:  Diabetologia       Date:  2013-04-19       Impact factor: 10.122

9.  Low-density lipoprotein stimulation of mesangial cell fibronectin synthesis: role of protein kinase C and transforming growth factor-beta.

Authors:  R K Studer; P A Craven; F R DeRubertis
Journal:  J Lab Clin Med       Date:  1995-01

10.  Transcription factor FoxO1 is essential for enamel biomineralization.

Authors:  Ross A Poché; Ramaswamy Sharma; Monica D Garcia; Aya M Wada; Mark J Nolte; Ryan S Udan; Ji-Hye Paik; Ronald A DePinho; John D Bartlett; Mary E Dickinson
Journal:  PLoS One       Date:  2012-01-24       Impact factor: 3.240

View more
  9 in total

1.  Repression of microRNA-382 inhibits glomerular mesangial cell proliferation and extracellular matrix accumulation via FoxO1 in mice with diabetic nephropathy.

Authors:  Shan Wang; Xin Wen; Xin-Rui Han; Yong-Jian Wang; Min Shen; Shao-Hua Fan; Juan Zhuang; Zi-Feng Zhang; Qun Shan; Meng-Qiu Li; Bin Hu; Chun-Hui Sun; Dong-Mei Wu; Jun Lu; Yuan-Lin Zheng
Journal:  Cell Prolif       Date:  2018-04-27       Impact factor: 6.831

2.  Hyperoside Alleviates High Glucose-Induced Proliferation of Mesangial Cells through the Inhibition of the ERK/CREB/miRNA-34a Signaling Pathway.

Authors:  Le Zhang; Qian Dai; Lanlan Hu; Hua Yu; Jing Qiu; Jiyin Zhou; Min Long; Shiwen Zhou; Kebin Zhang
Journal:  Int J Endocrinol       Date:  2020-07-21       Impact factor: 3.257

3.  FOXO1 expression in chondrocytes modulates cartilage production and removal in fracture healing.

Authors:  Zhenjiang Ding; Min Qiu; Mohammed A Alharbi; Tiffany Huang; Xiyan Pei; Tatyana N Milovanova; Hongli Jiao; Chanyi Lu; Min Liu; Ling Qin; Dana T Graves
Journal:  Bone       Date:  2021-03-01       Impact factor: 4.626

4.  Vitamin D3 Activates Phosphatidylinositol-3-Kinase/Protein Kinase B via Insulin-Like Growth Factor-1 to Improve Testicular Function in Diabetic Rats.

Authors:  Yanyan He; Yang Liu; Qing-Zhu Wang; Feng Guo; Fengjuan Huang; Linlin Ji; Tingting An; Guijun Qin
Journal:  J Diabetes Res       Date:  2019-06-04       Impact factor: 4.011

5.  Endothelial cells secreted endothelin-1 augments diabetic nephropathy via inducing extracellular matrix accumulation of mesangial cells in ETBR-/- mice.

Authors:  Hong-Hong Zou; Li Wang; Xiao-Xu Zheng; Gao-Si Xu; Yunfeng Shen
Journal:  Aging (Albany NY)       Date:  2019-03-29       Impact factor: 5.682

6.  MicroRNA-499a (rs3746444A/G) gene variant and susceptibility to type 2 diabetes-associated end-stage renal disease.

Authors:  Manal S Fawzy; Essam Al Ageeli; Saeed Awad Al-Qahtani; Baraah T Abu Alsel; Shahad W Kattan; Walla Alelwani; Eman A Toraih
Journal:  Exp Ther Med       Date:  2021-11-22       Impact factor: 2.447

7.  Involvement of Endoplasmic Reticulum Stress, Autophagy, and Apoptosis in Advanced Glycation End Products-Induced Glomerular Mesangial Cell Injury.

Authors:  Chih-Kang Chiang; Ching-Chia Wang; Tien-Fong Lu; Kuo-How Huang; Meei-Ling Sheu; Shing-Hwa Liu; Kuan-Yu Hung
Journal:  Sci Rep       Date:  2016-09-26       Impact factor: 4.379

8.  BKCa Mediates Dysfunction in High Glucose Induced Mesangial Cell Injury via TGF-β1/Smad2/3 Signaling Pathways.

Authors:  Zhigui Wu; Wenxian Yin; Mengqi Sun; Yuankai Si; Xiaoxiao Wu; Meijuan Chen
Journal:  Int J Endocrinol       Date:  2020-04-29       Impact factor: 3.257

9.  FoxO1-mediated inhibition of STAT1 alleviates tubulointerstitial fibrosis and tubule apoptosis in diabetic kidney disease.

Authors:  Fengjuan Huang; Qingzhu Wang; Feng Guo; Yanyan Zhao; Linlin Ji; Tingting An; Yi Song; Yang Liu; Yanyan He; Guijun Qin
Journal:  EBioMedicine       Date:  2019-10-16       Impact factor: 8.143

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.